Other primary outcomes included PD motor complications as measured by MDS-UPDRS Part IV in endpoints of included studies, motor experiences of daily living in PD patients as measured by MDS-UPDRS Part II in endpoints of included studies, gastrointestinal adverse events of GLP-1 receptor agonists, including dyspepsia, vomiting, diarrhea, and constipation, as well as general adverse events such as headache and fatigue
However, some more serious risks are non-arteritic anterior ischemic optic neuropathy, a form of permanent eye stroke, and diabetic retinopathy, a worsening of existing diabetic eye disease
Ready to build a body and a lifestyle you love?
At Set Point Medical, our professional medical team closely monitors each patients progress, adjusting the treatment as needed to ensure the best possible results while minimising any discomfort